Capital Stock | Note 5. Capital Stock Authorized Capital Authorized capital stock consists of 200,000,000 shares of Common Stock with par value of $0.01 per common share (2020- 50,000,000 shares of Common Stock with par value $0.01 per common share). An increase to authorized capital stock was approved by the Company’s stockholders during the year-ended June 30, 2021. During the year-ended June 30, 2021, the Company issued 3,209,133 shares at an approximate average price of $1.21 through its at-the market offering. Share issuance costs related to this were $157,979. The Company also issued 362,427 shares for payment of interest accrued and owing (Note 4 and Note 6) with a fair value of $398,777. The Company also issued 1,200,000 shares upon the conversion of 1,200 of the 2019 Senior Secured Convertible Notes (Note 4 and Note 6). In addition, during the year-ended June 30, 2021, the Company issued 166,792 shares at a value of $1.09 per share of Common Stock to Ausenco in exchange for services to complete a feasibility study at its Grassy Mountain Project (Note 4). It also issued 257,353 shares for the purchase of a mineral property with a fair value of $$277,941 (Note 4 and 7). During the year-ended June 30, 2020, the Company issued 1,096,791 shares at a value of $0.89 per share to Ausenco in exchange for services to complete a feasibility study at its Grassy Mountain Project (Note 4) . During the year-ended June 30, 2020, the Company issued 4,807,700 shares at a price of $1.04 per share for gross proceeds of $5,000,008. Share issuance costs were $421,558 for net proceeds of $4,578,450. During the year ended June 30, 2020, the Company issued 372,742 shares at an average approximate price of $1.17 for gross proceeds of $436,783 through its at-the-market offering. Share issuance costs, including one-time transaction costs and commissions were $124,265 for net proceeds of $312,518. At June 30, 2021 there were 38,154,109 common shares issued and outstanding (June 30, 2020 – 32,958,404 common shares). Warrants A summary of warrants exercisable into common stock as of June 30, 2021, and changes during years-ended June 30, 2021 and 2020 are presented below: Warrants Weighted Average Exercise Weighted- Average Remaining Contractual Term (Years) Aggregate Intrinsic ($) Outstanding at July 1, 2019 1,200,000 $ 1.40 1.03 — Issued — — — — Expired — — — — Exercised — — — — Outstanding at June 30, 2020 1,200,000 $ 1.40 0.03 — Issued — — — — Expired (1,200,000) 1.40 — — Exercised — — — — Outstanding at June 30, 2021 — $ — — — Stock Options and Stock Based Compensation Paramount’s 2015 and 2016 Stock Incentive and Compensation Plan, which is shareholder-approved, permits the grant of share options and shares to its employees for up to 2.169 million shares of common stock. Option awards are generally granted with an exercise price equal to the market price of Paramount’s stock at the date of grant and have contractual lives of 5 years. To better align the interests of its key executives, employee and directors with those of its shareholders a significant portion of those share option awards will vest contingent upon meeting certain stock price appreciation performance goals and other performance conditions. Option and share awards provide for accelerated vesting if there is a change in control (as defined in the employee share option plan).For the year-ended June 30, 2021, the Company granted 755,000 For the year-ended June 30, 2021, share-based compensation expense relating to service conditions options and performance conditions were $286,096 and $150,681, respectively (2020 - $73,509 and $129,683). The fair value for these options was calculated using the Black-Scholes option valuations method. The weighted average assumptions used for the fiscal years ending June 30, 2021 and 2020 were as follows: 2021 2020 Weighted average risk-free interest rate 0.22 % 1.60 % Weighted-average volatility 60.00 % 61.00 % Expected dividends 0.00 0.00 Weighted average expected term (years) 5 5 Weighted average fair value $ 0.57 $ 0.39 A summary of option activity under the Stock Incentive and Compensation Plan as of June 30, 2021 and 2020, and changes during the years ended June 30, 2021 and 2020 are presented below. Options Options Weighted Average Exercise Weighted-Average Remaining Contractual Aggregate Intrinsic ($) Outstanding at July 1, 2019 1,568,995 $ 1.50 1.95 $ — Granted 690,000 1.00 4.47 165,600 Exercised — — — — Forfeited or expired (1,015,000 ) 1.53 0.05 — Outstanding at June 30, 2020 1,243,995 $ 1.20 3.63 $ 165,600 Granted 755,000 1.13 4.44 — Exercised — — — — Forfeited or expired — — — — Outstanding at June 30, 2021 1,998,995 $ 1.17 $ 3.31 $ — Exercisable at June 30, 2021 964,997 $ 1.19 $ 3.08 $ — A summary of the status of Paramount’s non-vested options as of June 30, 2021 and 2020 and changes during the years ended June 30, 2021 and 2020 are presented below. Non-vested Options Options Weighted- Average Value Non-vested at July 1, 2019 340,660 $ 0.79 Granted 690,000 0.38 Vested (66,668 ) 0.74 Forfeited (20,000 ) 0.74 Nonvested at June 30, 2020 943,992 $ 0.51 Granted 755,000 0.56 Vested (664,994 ) 0.50 Forfeited — — Nonvested at June 30, 2021 1,033,998 $ 0.55 As of June 30, 2021 and 2020, there was $143,998 and $153,802 respectively of total unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the employee share option plan. That cost is expected to be recognized over a weighted-average period of 0.78 years (2020 – $1.05). The total fair value of shares vested during the years ended June 30, 2021 and 2020, was $332,835 and $202,121, respectively. |